ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OPTI Optibiotix Health Plc

18.25
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.25 17.50 19.00 18.25 18.25 18.25 144,329 07:39:19
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.43 16.64M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18.25p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.64 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.43.

Optibiotix Health Share Discussion Threads

Showing 54126 to 54148 of 147575 messages
Chat Pages: Latest  2171  2170  2169  2168  2167  2166  2165  2164  2163  2162  2161  2160  Older
DateSubjectAuthorDiscuss
03/7/2019
09:42
Revenues??
rastamouse
03/7/2019
09:40
If be surprised and happy IF we hold on to this little gain today.
It means my Spreadbets are actually in positive territory, which has been a rarity.
Onwards and upwards 😊
John

2350220
03/7/2019
09:39
This is a prime example of Opti building & completing supply chains in major territories. 'EIWA will have the exclusive rights to import, market and distribute'. This means they buy from Sacco & produce a product tailored for their client in either food/supplements or dairy. Today's deal will most probably be their customer rather than one Opti have engaged. EIWA are basically a sales team in japan for LPLDL. Whoever they distribute LPLDL to will have to have a license via Opti for the rights to sell a finished product, today is the first example. It's slow but it's ridiculously cost effective because in effect we have a Japanese sales team that have decades of experience in the market. Once all aligned across multiple territories the flow of cash from the licenses rolls in from the major markets in the world & the costs remain static. This is how you build a global brand for peanuts whilst enhancing the revenue & most importantly profit opportunity significantly.
riskybusiness1
03/7/2019
09:27
The lack of trading volume after all these deals shows that SOH is right to turn his attention to the investor side of things. Hopefully he can get this share price motoring over the summer.

As an aside, when is the big alfasigma launch due? I thought that was supposed to be soon back in April. That should generate some decent revenues once up and running.

imnotlong
03/7/2019
09:24
In the last results the revenue growth was gearing up in last few months of that period as was stated by SOH ,so not sure why the comment we know first half numbers are not going to be great.
I’m expecting a continuation of that rate of growth and above and if we don’t get it this will drop quite sharply I would suggest

best1467
03/7/2019
08:40
cant wait LOL
humphries1
03/7/2019
08:31
Hopefully, the side effect will be making a bit of money ... eventually :)
m4rtinu
03/7/2019
08:23
Ramas- I think you need to do a bit more research, this is science backed and it is peer reviewed. There are no side effects!
primal123
03/7/2019
08:23
>> ramas

LPLDL has GRAS status in the US which means you can eat it in food. Slimbiome has medical device status in Europe which again signifies that there is substantial data to show it is completely safe as a food supplement. Nuff said...

nobbygnome
03/7/2019
08:12
iis and pis still need time to comprehend how a licencing , virtual production model works , just like ARM as it sat at 150p before rocketing to 10000p in short order before then being acquired. There is one risk here and that is that the product doesn't work or damages you so if anyone want to put that case to me I'm interested to listen ....failing that patience needed while the dinosaurs digest the business model.
ramas
03/7/2019
08:09
Smarner

Not even worth trying to value Opti as the weekly addition of new deals and products keeps rendering projections out of date.

We all know H1 won’t be brilliant but soh has hinted full year numbers will be good and then just keep growing.

There’s so much going on that I would hate to not be in here.

S

shrewdmole
03/7/2019
08:09
Oh dear, I have a new troll. Sorry guys, buywell3 is another super troll.
nobbygnome
03/7/2019
08:06
Ether way, no harm done to your imaginary short. Turkey.
slartybartfaster
03/7/2019
08:06
I am sure we will see multiple deals coming out of Japan through EIWA. This is just the first.
parob
03/7/2019
08:05
Turnover 0.51

Cash raise coming IMO

buywell3
03/7/2019
08:05
So you sign a deal in the third biggest market in the world and it adds about £1 million to the market cap. Completely mad....
nobbygnome
03/7/2019
08:02
Thanks for that list Parob. If Opti keeps adding contracts/agreements like this you're gonna need a toilet roll soon if you want to print it out : )How can anyone think this company isn't going places?Sienna
siennadelekat21
03/7/2019
07:58
Whitegold

As he earlier deals start to come on line after product development the revenues will be growing all the time now. Meanwhile Opti just keep tying up more partners for etch and new strains and products.

We’ve still got 2 sbtx deals to be announced, one with a global.
Update on sweetbiotix is well over due.
Additional seed deal for the expanded countries.

Soh interview the other day was a clear indication of the commercial traction they now have.

Steve

shrewdmole
03/7/2019
07:57
Over 50 manufacturing & distribution agreements. Conservative estimated average value anyone?
smarner
03/7/2019
07:57
I need to update my list below for Seed Health. They are not just a US LP-LDL distributor, they are now a GLOBAL LP-LDL distributor, shipping to 44 countries.
parob
03/7/2019
07:55
Aye ! 'God' help the anti opti hate mob when the mist does lift and the 'seeds' start hitting continual winners !

lol

reckless kelly
03/7/2019
07:53
Look at that list of contracts Hami. Why not raise a glass and toast our excellent product and sales team. Well done Opti - hats off to the likes of Primal, Elrico etc who put in the miles to keep us updated in the face of much scurillous shorter garbage. Onwards and upwards.GLA.
whitegold1
03/7/2019
07:50
I was disappointed at the lack of an AGM trading update but look forward to Results soon when the Outlook statement will be of particular significance as I doubt whether any one can estimate with any accuracy our projected current year Revenues , including SOH.
Glad to have increased substantially at around 75p a few weeks ago & now in bottom draw until the mist lifts on our potential-which i expect to be substantial

base7
Chat Pages: Latest  2171  2170  2169  2168  2167  2166  2165  2164  2163  2162  2161  2160  Older

Your Recent History

Delayed Upgrade Clock